[Value of serum sialic acid determination in children]

A Seider1, N Graf, F C Sitzmann

  • 1Klinik für Kinder- und Jugendmedizin, Universität des Saarlandes, Homburg/Saar, Bundesrepublik Deutschland.

Padiatrie Und Padologie
|January 1, 1992
PubMed

Insights

Sialic acid (SA) levels are elevated in children with inflammatory diseases and malignant disorders. SA may be a useful tumor marker for monitoring patients with cancer.

Area of Science:

  • Biochemistry
  • Pediatric Oncology
  • Clinical Chemistry

Context:

  • Sialic acid (SA) is a key component of glycoproteins and glycolipids.
  • Tumor markers are crucial for cancer diagnosis and monitoring.
  • Pediatric serum samples were analyzed to assess SA concentrations.

Purpose:

  • To investigate the potential of sialic acid (SA) as a tumor marker in children.
  • To compare SA levels in healthy children, those with inflammatory diseases, and those with malignant disorders.

Summary:

  • Sialic acid (SA) concentrations were measured in 48 healthy children and 168 sick children.
  • Healthy children under six months had lower SA levels (41 +/- 5 mg/dl) than older children (68 +/- 8 mg/dl).
  • Elevated SA levels were observed in children with inflammatory diseases (93 +/- 28 mg/dl) and malignant disorders (83 +/- 27 mg/dl), though not exceeding inflammatory levels.

Impact:

  • Sialic acid (SA) shows potential as a biomarker in pediatric oncology.
  • SA may aid in the follow-up protocols for children diagnosed with malignant tumors.
  • Further research is warranted to establish SA's role in clinical practice.